EGFR and neoplasm: By contrast, some studies have found disparity between the expression levels of EGFR and tumor uptake of radiolabeled cetuximab in several tumor xenograft models from different origins, implying the influence of other factors such as pharmacokinetics and dynamics for cetuximab accumulation in tumors [14, 15].